We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.04B
AUM Growth
+$164M
Cap. Flow
-$244M
Cap. Flow %
-3.03%
Top 10 Hldgs %
72.74%
Holding
123
New
10
Increased
29
Reduced
37
Closed
40

Top Buys

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$171M
2
ELV icon
Elevance Health
ELV
+$30.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.2M
4
ISRG icon
Intuitive Surgical
ISRG
+$14.8M
5
HUM icon
Humana
HUM
+$13.9M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$139M
2
JNJ icon
Johnson & Johnson
JNJ
+$45.8M
3
ECL icon
Ecolab
ECL
+$41.6M
4
UNH icon
UnitedHealth
UNH
+$33.4M
5
PFE icon
Pfizer
PFE
+$32.3M

Sector Composition

Rank Sector Weight
1 Financials 24.06%
2 Consumer Discretionary 16.59%
3 Healthcare 13.94%
4 Consumer Staples 10.32%
5 Materials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
76
Pfizer
PFE
$144B
$565K 0.01%
13,737
-812,760
-98% -$32.3M
MELI icon
77
Mercado Libre
MELI
$93.9B
$482K 0.01%
+787
New +$438K
FIS icon
78
Fidelity National Information Services
FIS
$23.7B
$441K 0.01%
3,597
-2,714
-43% -$319K
JNJ icon
79
Johnson & Johnson
JNJ
$642B
$428K 0.01%
3,073
-331,047
-99% -$45.8M
GPRK icon
80
GeoPark
GPRK
$612M
$265K ﹤0.01%
14,364
-3,613
-20% -$60.4K
ATHM icon
81
Autohome
ATHM
$2.61B
$208K ﹤0.01%
+2,423
New +$241K
PAGS icon
82
PagSeguro Digital
PAGS
$2.69B
$192K ﹤0.01%
+4,941
New +$153K
ABBV icon
83
AbbVie
ABBV
$471B
– –
-125,780
Closed -$10.1M
ACHC icon
84
Acadia Healthcare
ACHC
$2.63B
– –
-53,712
Closed -$1.57M
ACRS icon
85
Aclaris Therapeutics
ACRS
$723M
– –
-148,506
Closed -$890K
AMGN icon
86
Amgen
AMGN
$212B
– –
-80,787
Closed -$15.3M
ARMK icon
87
Aramark
ARMK
$15.1B
– –
-90,046
Closed -$1.92M
AVY icon
88
Avery Dennison
AVY
$12.8B
– –
-3,500
Closed -$396K
BDX icon
89
Becton Dickinson
BDX
$46.1B
– –
-54,279
Closed -$13.2M
BIIB icon
90
Biogen
BIIB
$31.8B
– –
-41,551
Closed -$9.82M
BSX icon
91
Boston Scientific
BSX
$68.8B
– –
-367,194
Closed -$14.1M
CI icon
92
Cigna
CI
$79B
– –
-30,018
Closed -$4.83M
COLL icon
93
Collegium Pharmaceutical
COLL
$1.18B
– –
-236,021
Closed -$3.57M
GILD icon
94
Gilead Sciences
GILD
$165B
– –
-196,598
Closed -$12.8M
HCA icon
95
HCA Healthcare
HCA
$90.8B
– –
-112,905
Closed -$14.7M
HOLX
96
DELISTED
Hologic
HOLX
– –
-199,328
Closed -$9.65M
INCY icon
97
Incyte
INCY
$25.4B
– –
-38,726
Closed -$3.33M
IOVA icon
98
Iovance Biotherapeutics
IOVA
$2.03B
– –
-226,681
Closed -$2.16M
JAZZ icon
99
Jazz Pharmaceuticals
JAZZ
$16B
– –
-29,774
Closed -$4.26M
LIVN icon
100
LivaNova
LIVN
$4.48B
– –
-83,163
Closed -$8.09M
1 2 3
4
5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2019 Portfolio in Review

As of Q2 2019, C WorldWide Group held 123 positions worth $8.04B, up 2.1% from $7.88B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group withdrew a net $244M in Q2 2019, closing 40 positions and reducing 37 holdings. Its most notable exit was Amgen, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, C WorldWide Group opened a new position in MSCI worth $183M.

  • C WorldWide Group's largest Q2 2019 buy was MSCI: 764,587 shares worth $183M.
  • C WorldWide Group added most to Elevance Health in Q2 2019, an estimated $30.9M increase.
  • C WorldWide Group's biggest Q2 2019 reduction was Visa, cutting an estimated $139M.
  • C WorldWide Group fully exited Amgen in Q2 2019, selling an estimated $15.3M.
  • C WorldWide Group's ten largest holdings make up 73% of its $8.04B portfolio in Q2 2019.
  • C WorldWide Group opened 10 new positions and closed 40 in Q2 2019.
  • C WorldWide Group's portfolio value rose 2.1% quarter-over-quarter to $8.04B.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.